| 000 | 01662 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516013111.0 | ||
| 264 | 0 | _c20110725 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1521-0464 | ||
| 024 | 7 |
_a10.3109/10717544.2010.536271 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeng, Fei-Fei | |
| 245 | 0 | 0 |
_aGrowth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension. _h[electronic resource] |
| 260 |
_bDrug delivery _cMay 2011 |
||
| 300 |
_a265-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCaspase 3 _xgenetics |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDiterpenes, Kaurane _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aG2 Phase _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNanoparticles _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 |
_aSuspensions _xadministration & dosage |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xgenetics |
| 700 | 1 | _aZhang, Dian-Rui | |
| 700 | 1 | _aTian, Ke-Li | |
| 700 | 1 | _aLou, Hai-Yan | |
| 700 | 1 | _aQi, Xiao-Li | |
| 700 | 1 | _aWang, Yan-Cai | |
| 700 | 1 | _aDuan, Cun-Xian | |
| 700 | 1 | _aJia, Le-Jiao | |
| 700 | 1 | _aWang, Fei-Hu | |
| 700 | 1 | _aLiu, Yue | |
| 700 | 1 | _aZhang, Qiang | |
| 773 | 0 |
_tDrug delivery _gvol. 18 _gno. 4 _gp. 265-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10717544.2010.536271 _zAvailable from publisher's website |
| 999 |
_c20387637 _d20387637 |
||